Association of coffee and caffeine intake with the risk of Parkinson disease.
暂无分享,去创建一个
C. Tanner | D. Morens | R. Abbott | J. Curb | L. White | G. Ross | K. Masaki | H. Petrovitch | A. Grandinetti | R D Abbott | P. Blanchette | C M Tanner | J. Popper | J S Popper | H Petrovitch | L R White | K H Masaki | J D Curb | A Grandinetti | P L Blanchette | G W Ross | D M Morens | K. Tung | K H Tung | LonR. White | David M. Morens | Andrew Grandinetti | Robert D. Abbott | Kamal H. Masaki | Ko-Hui Tung | Caroline M. Tanner | Patricia L. Blanchette | Patricia L. Blanchette | K. Masaki
[1] Ward Cd,et al. Research diagnostic criteria for Parkinson's disease. , 1990 .
[2] D J Foley,et al. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. , 1996, JAMA.
[3] Daniel L. McGee,et al. Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics. , 1984, American journal of epidemiology.
[4] H. Watanabe,et al. Caffeine mimics dopamine receptor agonists without stimulation of dopamine receptors , 1986, Neuropharmacology.
[5] D. Morens,et al. Epidemiologic observations on Parkinson's disease , 1996, Neurology.
[6] D. Reed,et al. Coffee, caffeine, and serum cholesterol in Japanese men in Hawaii. , 1986, American journal of epidemiology.
[7] L. Heilbrun,et al. The origins of epidemiologic studies of heart disease, cancer and osteoporosis among Hawaii Japanese. , 1985, Hawaii medical journal.
[8] J. Hankin,et al. Within-person variability of nutrient intake in a group of Hawaiian men of Japanese ancestry. , 1982, The American journal of clinical nutrition.
[9] P. Jenner,et al. Adenosine A2A receptors modify motor function in MPTP‐treated common marmosets , 1998, Neuroreport.
[10] I. Shoulson,et al. Studies with bromocriptine , 1976, Neurology.
[11] D. Morens,et al. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. , 1994, American journal of epidemiology.
[12] P. W. Lane,et al. Analysis of covariance and standardization as instances of prediction. , 1982, Biometrics.
[13] D. Calne,et al. Assessment of Parkinson's Disease , 1984, Clinical neuropharmacology.
[14] C. Tanner. Epidemiology of Parkinson’s Disease , 1992, Neurologic Clinics.
[15] M. Caporali,et al. Akinesia due to catecholamine depletion in mice is prevented by caffeine. Further evidence for an involvement of adenosinergic system in the control of motility , 1991, The Journal of pharmacy and pharmacology.
[16] D.,et al. Regression Models and Life-Tables , 2022 .
[17] I. Shoulson,et al. Caffeine and the antiparkinsonian response to levodopa or piribedil , 1975, Neurology.
[18] R. Worth,et al. Ascertainment of men of Japanese ancestry in Hawaii through World War II Selective Service registration. , 1970, Journal of chronic diseases.
[19] J. Langston,et al. Epidemiology versus genetics in parkinson's disease: Progress in resolving an age‐old debate , 1998, Annals of neurology.
[20] J. Málly,et al. The effect of theophylline on parkinsonian symptoms , 1994, The Journal of pharmacy and pharmacology.
[21] A. Lang,et al. Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.
[22] J W Langston,et al. Parkinson disease in twins: an etiologic study. , 1999, JAMA.
[23] G. Ulm,et al. Diet and Parkinson's disease II , 1996, Neurology.
[24] D. Mateo,et al. Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: A case‐control study , 1992, Movement disorders : official journal of the Movement Disorder Society.
[25] G. Román,et al. Worldwide occurrence of Parkinson's disease: an updated review. , 1993, Neuroepidemiology.
[26] Langston Jw. Epidemiology versus genetics in parkinson's disease: Progress in resolving an age-old debate , 1998 .
[27] Astrid Nehlig,et al. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects , 1992, Brain Research Reviews.
[28] O. Axelson,et al. Nutritional and occupational factors influencing the risk of Parkinson's disease: A case‐control study in southeastern Sweden , 1999, Movement disorders : official journal of the Movement Disorder Society.
[29] M. Nefzger,et al. A retrospective study of smoking in Parkinson's disease. , 1968, American journal of epidemiology.
[30] P. Jenner,et al. Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease. , 1997, Trends in pharmacological sciences.